|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.46 USD | -0.57% |
|
+6.35% | -29.15% |
| Dec. 12 | Morgan Stanley Adjusts Moderna Price Target to $28 From $30, Maintains Equalweight Rating | MT |
| Dec. 12 | Rate Cuts Can't Buy Confidence |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 11.51B | - | ||||
| 76.06B | |||||
| 58.92B | |||||
| 53.01B | |||||
| 52.48B | |||||
| 25.54B |
- Stock Market
- Equities
- MRNA Stock
- Charts Moderna, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
